FDA Drug Recalls

Recalls / Class III

Class IIID-1166-2014

Product

Advil PM Caplets, (Ibuprofen, 200 mg /Diphenhydramine citrate, 38 mg) 120 count bottle, OTC, Pfizer, Madison, NJ 07940 USA. NDC 0573-0164-43

Brand name
Advil Pm
Generic name
Diphenhydramine Citrate And Ibuprofen
Active ingredients
Diphenhydramine Citrate, Ibuprofen
Route
Oral
NDC
0573-0164
FDA application
NDA021394
Affected lot / code info
G85041

Why it was recalled

Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.

Recalling firm

Firm
Pfizer Us Pharmaceutical Group
Manufacturer
Haleon US Holdings LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
235 E 42nd St, New York, New York 10017-5703

Distribution

Quantity
70,704 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2014-02-26
FDA classified
2014-03-18
Posted by FDA
2014-03-26
Terminated
2015-07-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1166-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Advil Pm · FDA Drug Recalls